Beta Bionics, Inc. (BBNX) NASDAQ

26.55

-1.2572(-4.52%)

Updated at November 05 12:56PM

Currency In USD

Valuation

Market Cap150.41M
Enterprise Value127.23M
P/E Ratio-15.59
PEG Ratio-0.42
Price/Sales Ratio13.82
Price/Book Ratio4.12
Enterprise/Revenue13.47
Enterprise/EBITDA-18.26

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.88
Operating Margin-0.77

Management Effectiveness

Return On Assets-0.24
Return On Equity-0.32

Income Statement

Revenue65.12M
Revenue/Share2.03
Gross Profit35.89M
EBITDA-44.1M
Net Income-54.76M
Diluted EPS-8.6

Balance Sheet

Total Cash228.69M
Total Cash/Share5.24
Total Debt7.69M
Total Debt/Equity0.03
Current Ratio10.64
Book Value Per Share6.76

Price History

52-Week Change17.69
52-Week High30.47
52-Week Low8.89
Moving Average 50 Days22.24
Moving Average 200 Days17.37

Statistics

Average Volume807,678
Shares Outstanding44.02M
% Held by Institutions103.37

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A